AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ISLAND PHARMACEUTICALS LTD

0.490

+0.0306.52%

Volume:712.01K

Turnover:344.85K

Market Cap:144.44M

PE:-15.54

High:0.500

Open:0.465

Low:0.465

Close:0.460

52wk High:0.630

52wk Low:0.200

Shares:294.77M

Float Shares:110.76M

Volume Ratio:11.50

T/O Rate:0.64%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.032

EPS(LYR):-0.023

ROE:-130.31%

ROA:-74.67%

PB:20.18

PE(LYR):-21.67

Loading ...

Overview Company News Filings

Island Pharmaceuticals Boosts Galidesivir Supply Amid Ebola Outbreak, Shares Up 4%

MT Newswires Live

Island Pharmaceuticals Ltd - Island Boosts Galidesivir Supply as Ebola Surges

THOMSON REUTERS

Island Pharmaceuticals - Additional Production of Gmp-Grade Galidesivir Commissioned with Pi Health Sciences

THOMSON REUTERS

Island Pharmaceuticals Signs Statement of Work With Texas Biomed to Advance Galidesivir, Shares Hit Six Month High

MT Newswires Live

Island Pharmaceuticals Ltd-texas Biomed Sow Accelerates Pivotal FDA Pathway

THOMSON REUTERS

Insider Sales At Island Pharmaceuticals Landed A Good Price

Simply Wall St.

Island Pharmaceuticals Hits Seven-month High on Galidesivir Approval for Ebola Epidemic

Island Pharmaceuticals Secures Regulatory Approvals for Compassionate Treatment Using Drug Candidate for Uganda Ebola Virus Patients

MT Newswires Live

Island Pharmaceuticals Ltd-galidesivir Approved for Treatment Use in in Ebola Epidemic

THOMSON REUTERS

Island Pharmaceuticals - Galidesivir to be Deployed Within Cy26

THOMSON REUTERS

Island Pharmaceuticals Requests Trading Halt Pending Antiviral Drug Candidate Trial Update

MT Newswires Live

Island Pharmaceuticals Seeks Trading Halt

Island Pharmaceuticals - Trading Halt Pending Announcement on Galidesivir Use in Ebola Clinical Trial in Africa

THOMSON REUTERS

Island Pharmaceuticals Says Singapore Granted Patent for Antiviral Therapy; Shares Jump 4%

MT Newswires Live

Island Pharmaceuticals Secures US FDA Orphan Drug Status for Antiviral Candidate

MT Newswires Live

Island Pharmaceuticals Ltd-FDA Grants Orphan Designation for Galidesivir in Marburg

THOMSON REUTERS

Island Pharmaceuticals Ltd-Investor Presentation (Updated)

THOMSON REUTERS

BUZZ-Australia's Island Pharmaceuticals rises on agreement extension with US Army

Island Pharmaceuticals Secures Agreement Expansion With US Army Medical Research Institute of Infectious Diseases; Shares Up 3%

MT Newswires Live

Island Pharmaceuticals Ltd-Island Secures Usamriid Support for Galidesivir Study

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/ILA.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ILA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ILA.AU\",,,,,undefined,":{"symbol":"ILA.AU","market":"AU","secType":"STK","nameCN":"ISLAND PHARMACEUTICALS LTD","latestPrice":0.49,"timestamp":1787292720000,"preClose":0.46,"halted":0,"volume":712012,"delay":0,"changeRate":0.06521739130434775,"nameEN":"ISLAND PHARMACEUTICALS LTD","floatShares":110756995,"shares":294766682,"eps":-0.031527,"marketStatus":"Market Closed","change":0.03,"latestTime":"08-21 16:12:00 AEST","open":0.465,"high":0.5,"low":0.465,"amount":344845,"amplitude":0.076087,"askPrice":0.5,"askSize":6286,"bidPrice":0.485,"bidSize":12636,"shortable":3,"etf":0,"ttmEps":-0.031527,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.46,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":11.504252623959465,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ILA.AU","preClose":0.46,"auctionPrice":0.49,"auctionVolume":4163,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292594863}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ILA.AU\",,,,,undefined,":{"symbol":"ILA.AU","floatShares":110756995,"roa":"-74.67%","roe":"-130.31%","lyrEps":-0.022614,"volumeRatio":11.504252623959465,"shares":294766682,"dividePrice":0,"high":0.5,"amplitude":0.076087,"preClose":0.46,"low":0.465,"week52Low":0.2,"pbRate":"20.18","psRate":"2298.06","week52High":0.63,"institutionHeld":0,"latestPrice":0.49,"committee":0.335588,"eps":-0.031527,"divideRate":0,"volume":712012,"delay":0,"ttmEps":-0.031527,"open":0.465,"prevYearClose":0.43,"prevWeekClose":0.44,"prevMonthClose":0.39,"prevQuarterClose":0.38,"fiveDayClose":0.44,"twentyDayClose":0.4,"sixtyDayClose":0.39,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ILA.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ILA.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ILA.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661532952","title":"Island Pharmaceuticals Boosts Galidesivir Supply Amid Ebola Outbreak, Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661532952","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661532952?lang=en_us&edition=fundamental","pubTime":"2026-08-21 08:43","pubTimestamp":1787272988,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  commissioned an additional production campaign of good manufacturing practice  grade antiviral drug Galidesivir with contract manufacturer PI Health Sciences, according to a Friday Australian bourse filing.The manufacturing is expected to be completed in the fourth quarter, providing up to about 800 treatment courses, per the filing.The company said the additional supply comes as the ongoing Ebola virus Bundibugyo strain outbreak continues to spread rapidly across Central Africa, with Galidesivir expected to be deployed in Uganda during the year, providing an opportunity to generate human efficacy, safety and virological data during an active outbreak.The company's shares rose 4% in recent Friday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661380258","title":"Island Pharmaceuticals Ltd - Island Boosts Galidesivir Supply as Ebola Surges","url":"https://stock-news.laohu8.com/highlight/detail?id=2661380258","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661380258?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:57","pubTimestamp":1787266663,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nFWN44H1CC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661258387","title":"Island Pharmaceuticals - Additional Production of Gmp-Grade Galidesivir Commissioned with Pi Health Sciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2661258387","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661258387?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:57","pubTimestamp":1787266663,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nFWN44H1CC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651162755","title":"Island Pharmaceuticals Signs Statement of Work With Texas Biomed to Advance Galidesivir, Shares Hit Six Month High","url":"https://stock-news.laohu8.com/highlight/detail?id=2651162755","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651162755?lang=en_us&edition=fundamental","pubTime":"2026-07-13 10:13","pubTimestamp":1783908817,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  executed a statement of work  with the Texas Biomedical Research Institute to further advance Galidesivir's Animal Rule development for the treatment of Marburg Virus Disease, according to a Monday Australian bourse filing.Galidesivir is the company's clinical-stage antiviral molecule with a broad spectrum of activity in over 20 RNA viruses, including high-priority threats such as Ebola and Marburg, with the SOW providing the opportunity to advance a complementary Food and Drug Administration-directed dose optimisation study in a further 12 non-human primates.The company's shares rose 10% in recent Monday trade, reaching their highest price since December 2025.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651716150","title":"Island Pharmaceuticals Ltd-texas Biomed Sow Accelerates Pivotal FDA Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2651716150","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651716150?lang=en_us&edition=fundamental","pubTime":"2026-07-13 07:46","pubTimestamp":1783899975,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260712:nTUE3Z46P2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650137767","title":"Insider Sales At Island Pharmaceuticals Landed A Good Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2650137767","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650137767?lang=en_us&edition=fundamental","pubTime":"2026-07-11 04:39","pubTimestamp":1783715995,"startTime":"0","endTime":"0","summary":"While it’s been a great week for Island Pharmaceuticals Limited ( ASX:ILA ) shareholders after stock gained 20...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-ila/island-pharmaceuticals-shares/news/insider-sales-at-island-pharmaceuticals-landed-a-good-price","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-ila/island-pharmaceuticals-shares/news/insider-sales-at-island-pharmaceuticals-landed-a-good-price","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649605315","title":"Island Pharmaceuticals Hits Seven-month High on Galidesivir Approval for Ebola Epidemic","url":"https://stock-news.laohu8.com/highlight/detail?id=2649605315","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649605315?lang=en_us&edition=fundamental","pubTime":"2026-07-07 11:12","pubTimestamp":1783393921,"startTime":"0","endTime":"0","summary":"BUZZ-Island Pharmaceuticals hits seven-month high on Galidesivir approval for Ebola epidemic** Shares of Australia-based Island PharmaceuticalsILA.AXrise as much as 46.7% to A$0.550, hitting their hig","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4N43907F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649167272","title":"Island Pharmaceuticals Secures Regulatory Approvals for Compassionate Treatment Using Drug Candidate for Uganda Ebola Virus Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2649167272","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649167272?lang=en_us&edition=fundamental","pubTime":"2026-07-07 07:42","pubTimestamp":1783381324,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals (ASX:ILA) secured regulatory and ethics approvals for the compassionate use treatment using its Galidesivir drug candidate for patients infected with the Bundibugyo Ebola virus ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649672691","title":"Island Pharmaceuticals Ltd-galidesivir Approved for Treatment Use in in Ebola Epidemic","url":"https://stock-news.laohu8.com/highlight/detail?id=2649672691","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649672691?lang=en_us&edition=fundamental","pubTime":"2026-07-07 07:02","pubTimestamp":1783378945,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nTUEBRVR0P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649672612","title":"Island Pharmaceuticals - Galidesivir to be Deployed Within Cy26","url":"https://stock-news.laohu8.com/highlight/detail?id=2649672612","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649672612?lang=en_us&edition=fundamental","pubTime":"2026-07-07 07:02","pubTimestamp":1783378945,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nTUEBRVR0P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648630918","title":"Island Pharmaceuticals Requests Trading Halt Pending Antiviral Drug Candidate Trial Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2648630918","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648630918?lang=en_us&edition=fundamental","pubTime":"2026-07-03 11:11","pubTimestamp":1783048272,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  requested a trading halt on the Australian Securities Exchange, pending an update regarding the potential inclusion of its antiviral candidate, galidesivir, in an Ebola clinical trial in Africa, according to a Friday filing with the Australian bourse.The halt will remain in effect until the earlier of the company releasing the update or the commencement of trading on July 7, the filing added.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648637488","title":"Island Pharmaceuticals Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2648637488","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648637488?lang=en_us&edition=fundamental","pubTime":"2026-07-03 10:24","pubTimestamp":1783045466,"startTime":"0","endTime":"0","summary":"BRIEF-Island Pharmaceuticals Seeks Trading HaltJuly 3 (Reuters)-Island Pharmaceuticals LtdILA.AX:TRADING HALT PENDING ANNOUNCEMENT ON GALIDESIVIR USE IN EBOLA CLINICAL TRIAL IN AFRICAFurther company coverage:ILA.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260703:nFWN43410R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648763712","title":"Island Pharmaceuticals - Trading Halt Pending Announcement on Galidesivir Use in Ebola Clinical Trial in Africa","url":"https://stock-news.laohu8.com/highlight/detail?id=2648763712","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648763712?lang=en_us&edition=fundamental","pubTime":"2026-07-03 10:23","pubTimestamp":1783045394,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260703:nFWN43410R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648527257","title":"Island Pharmaceuticals Says Singapore Granted Patent for Antiviral Therapy; Shares Jump 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648527257","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648527257?lang=en_us&edition=fundamental","pubTime":"2026-07-02 08:33","pubTimestamp":1782952381,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  said Singapore's Intellectual Property Office granted a patent covering the use of its ISLA-101 drug candidate for the treatment of flavivirus and Chikungunya virus infections, according to a Thursday filing with the Australian bourse.Chikungunya is a mosquito-borne viral disease similar to dengue, which is also covered in the patent.The patent is owned by Monash University and protects the use of ISLA-101 as a standalone antiviral therapy until April 16, 2034, per the filing.\"Singapore is an important market within the Asia-Pacific region, where dengue and other mosquito-borne viral diseases remain endemic,\" the company said.The company's shares jumped 4% in recent Thursday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644532796","title":"Island Pharmaceuticals Secures US FDA Orphan Drug Status for Antiviral Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2644532796","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644532796?lang=en_us&edition=fundamental","pubTime":"2026-06-17 07:45","pubTimestamp":1781653529,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  secured an Orphan Drug Designation from the US Food and Drug Administration  for its antiviral candidate Galidesivir as a post-exposure prophylaxis for Marburg virus disease, according to a Wednesday filing with the Australian bourse.The designation offers regulatory and commercial benefits, including up to seven years of US market exclusivity if approved, along with fee waivers and increased FDA support, per the filing.The company also noted recent progress, including an expanded Cooperative Research and Development Agreement with the US Army Medical Research Institute of Infectious Diseases, securing a non-human primate supply for upcoming dose-optimization studies, and initiating GMP manufacturing.The company said that preparations for pivotal studies are ongoing, with the next development phase expected to start in the next quarter, the filing added.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","BK4588","LABU","ILA.AU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644795911","title":"Island Pharmaceuticals Ltd-FDA Grants Orphan Designation for Galidesivir in Marburg","url":"https://stock-news.laohu8.com/highlight/detail?id=2644795911","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644795911?lang=en_us&edition=fundamental","pubTime":"2026-06-17 06:54","pubTimestamp":1781650497,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nTUE2RNGHD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642408360","title":"Island Pharmaceuticals Ltd-Investor Presentation (Updated)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642408360","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642408360?lang=en_us&edition=fundamental","pubTime":"2026-06-11 10:25","pubTimestamp":1781144724,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nTUE4SVDLR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642106594","title":"BUZZ-Australia's Island Pharmaceuticals rises on agreement extension with US Army","url":"https://stock-news.laohu8.com/highlight/detail?id=2642106594","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642106594?lang=en_us&edition=fundamental","pubTime":"2026-06-10 13:56","pubTimestamp":1781070963,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Island Pharmaceuticals rises on agreement extension with US Army** Shares of Australia's Island Pharmaceuticals ILA.AX rise as much as 5.7% to A$0.37, their biggest intraday pct gain since May 21** The antiviral drug developer says it extends its existing cooperative research and development agreement  with the U.S. Army** Says the agreement advances the company's dose optimisation study evaluating Galidesivir for the treatment of fatal viral fever, Marburg Virus Disease** Says this allows company to prepare for operations and commercialization of the drug** YTD, stock down 15.1%, including day's moves  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nL6N42I0CB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642416204","title":"Island Pharmaceuticals Secures Agreement Expansion With US Army Medical Research Institute of Infectious Diseases; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2642416204","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642416204?lang=en_us&edition=fundamental","pubTime":"2026-06-10 09:15","pubTimestamp":1781054126,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals  secured an expansion to its cooperative research and development agreement with the US Army Medical Research Institute of Infectious Diseases, a part of the Defense Health Agency and The Geneva Foundation for Medical Research, according to a Wednesday filing with the Australian bourse.The expanded agreement confirms the company's planned dose optimization study evaluating Galidesivir, its treatment candidate for Marburg virus disease, the filing said.The study is expected to start next quarter with topline results in the second half of the year, per the filing.Shares rose 3% in morning trade on Wednesday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ILA.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642133304","title":"Island Pharmaceuticals Ltd-Island Secures Usamriid Support for Galidesivir Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2642133304","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642133304?lang=en_us&edition=fundamental","pubTime":"2026-06-10 06:53","pubTimestamp":1781045614,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nTUE2RNK6H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","ILA.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":32,"code":"91000000","status":"200"}]}}